Back to SUSQUEHANNA INTERNATIONAL GROUP, LLP SUSQUEHANNA INTERNATIONAL GROUP, LLP

GENEGENE
15 quarters

Position history for SUSQUEHANNA INTERNATIONAL GROUP, LLPSUSQUEHANNA INTERNATIONAL GROUP, LLP's holdings in GENETIC TECHNOLOGIES LTD

SUSQUEHANNA INTERNATIONAL GROUP, LLP previously held 0 shares of GENE (GENETIC TECHNOLOGIES LTD), worth $0 as of 2024-Q4.

Final Value

$0

Final Shares

0

Total Value Change

-$184,000

Total Shares Change

-53,316

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q4
Latest
Exited
0
-100.0%
$00.0%
0
2024-Q3
Decreased
27,617
-64.3%
$20,6690.0%
0
2024-Q2
Increased
77,303
+123.4%
$115,1810.0%
24
2024-Q1
New
34,596
-
$99,9820.0%
33
2023-Q1
Exited
0
-100.0%
$00.0%
0
2022-Q4
Increased
76,881
+148.2%
$69,9620.0%
23
2022-Q3
Decreased
30,980
-40.1%
$37,0000.0%
0
2022-Q2
Increased
51,703
+57.2%
$59,0000.0%
20
2022-Q1
Decreased
32,893
-39.0%
$65,0000.0%
0
2021-Q4
Increased
53,920
+53.3%
$102,0000.0%
21
2021-Q3
Decreased
35,172
-30.4%
$108,0000.0%
0
2021-Q2
Decreased
50,526
-25.2%
$215,0000.0%
0
2021-Q1
Decreased
67,527
-55.3%
$282,0000.0%
0
2020-Q4
Increased
151,024
+183.3%
$544,0000.0%
27
2020-Q3
New
53,316
-
$184,0000.0%
35

Other major holders of GENE: CITADEL ADVISORS LLC, GROUP ONE TRADING LLC, RENAISSANCE TECHNOLOGIES LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used